cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Anika Therapeutics Inc
9 own
16 watching
Current Price
$25.84
$0.41
(1.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
338.07M
52-Week High
52-Week High
28.58000
52-Week Low
52-Week Low
16.54000
Average Volume
Average Volume
0.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
30.56
iconMarket Capitalization338.07M
icon52-Week High28.58000
icon52-Week Low16.54000
iconAverage Volume0.05M
iconDividend Yield--
iconP/E Ratio30.56
What does the Anika Therapeutics Inc do?
Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a woven gauze used as a bone graft wrap; HYALOSS used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment. The company's dermal products include wound care products that comprise HYALOMATRIX and HYALOFILL for the treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise HYALOBARRIER, a post-operative adhesion barrier for use in the abdomino-pelvic area; INCERT, a HA product used for the prevention of post-surgical spinal adhesions; MEROGEL, a woven fleece nasal packing; and MEROGEL INJECTABLE, a viscous hydrogel. The company also offers ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; and veterinary products, which include HYVISC, an injectable HA product for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Read More
How much money does Anika Therapeutics Inc make?
News & Events about Anika Therapeutics Inc.
Globe Newswire
1 year ago
BEDFORD, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 22nd Annual Needham Virtual Healthcare Conference on Thursday, April 20, 2023. ...
Globe Newswire
1 year ago
Tactoset cleared by the FDA to be combined with autologous bone marrow aspirate, a core element for regenerative healing Anika reaches agreement to distribute the Marrow Cellution Bone Marrow Aspiration Needle in the U.S. and commences launch Launches enhanced Tactoset cannulas, which improve ...
Globe Newswire
1 year ago
BEDFORD, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK) (Anika or the Company), a global joint preservation company in early intervention orthopedics, today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (SEC...
Accesswire
1 year ago
NEW YORK, NY / ACCESSWIRE / March 20, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 22-23, 2023. The links can also be found at www.sidoticonference.com/events. Virtual...
Zolmax
1 year ago
Barrington Research cut shares of Anika Therapeutics (NASDAQ:ANIK Get Rating) from an outperform rating to a market perform rating in a research note released on Tuesday, Marketbeat reports. Barrington Research also issued estimates for Anika Therapeutics Q1 2024 earnings at ($0.25) EPS, Q2 2024 ...
Frequently Asked Questions
Frequently Asked Questions
What is Anika Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Anika Therapeutics Inc shares?
plus_minus_icon
How can I buy Anika Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Anika Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Anika Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Anika Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Anika Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Anika Therapeutics Inc?
plus_minus_icon
What percentage is Anika Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Anika Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$25.84
$0.41
(1.61%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00